Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website http://www.jofem.org

Original Article

Volume 7, Number 2, April 2017, pages 61-67


Glycemic Control Rate in Type 2 Diabetes Mellitus Patients at a Public Referral Hospital in Rio de Janeiro, Brazil: Demographic and Clinical Factors

Tables

Table 1. Clinical and Demographic Data
 
VariablesTotal, n (%)
aAge, patient’s age obtained at last evaluation. bFormer practice no longer present in the last medical visit. T2D: type 2 diabetes; CKD: chronic kidney disease; OAD: oral antidiabetic medication; BMI: body mass index; HbA1c: glycated hemoglobin.
Male/female321 (32.0%)/680 (68.0%)
Agea (years)61 (21 - 95)
Diabetes duration (years)10 (1 - 58)
T2D family history (n = 527)352 (66.8%)
Smoking (n = 639)
  Passedb/present236 (37.0%)/69 (10.8%)
Alcohol consumption (n = 589)
  Previousb/Present48 (8.1%)/11 (1.8%)
Hypertension812 (81.1%)
Dyslipidemia751 (75.0%)
CKD185 (18.5%)
Treatment
  Only OAD460 (46.0%)
  OAD + insulin363 (36.3%)
  Only basal insulin54 (5.4%)
  Basal + bolus insulin102 (10.2%)
Nutritional follow-up (n = 898)331 (36.9%)
Waist circumference (cm) (n = 206)100 (72 - 150)
BMI (kg/m2)29.50 (16.17 - 57.00)
Overweight/obesity223 (22.3%)/302 (30.2%)
HbA1c (%)7.3 (4.3 - 15.2)

 

Table 2. Factors Related to Satisfactory Glycemic Control Rate
 
VariablesHbA1c < targeta (n = 510; 51.0%)HbA1c > targeta (n = 491; 49.0%)P-value
aFor this analysis, we considered ADA’s goals for T2D patients as: HbA1c < 7.0% for young adults and < 8.0% for older than 70 years old, with serious microvascular or macrovascular complications, presence of severe hypoglycemia or several comorbidities, or with a limited life expectancy. bAge at last consultation. cFormer practice no longer present in the last medical visit. dIntermediate insulin (NPH) or long-acting analogues. eRapid insulin (regular) or ultra-rapid acting analogues. T2D: type 2 diabetes; CKD: chronic kidney disease; HbA1c: glycated hemoglobin; NS: not significant; OAD: oral antidiabetic medication.
Male/female53.0%/50.0%47.0%/50.0%NS
Ageb (years)64 (33 - 95)59 (21 - 91)< 0.001
Diabetes duration (years)10 (1 - 58)11 (1 - 46)0.057
T2D family history (n = 527)45.5%54.5%0.042
Previousc/present smoking (n = 639)53.8%/43.5%46.2%/56.5%NS
Previousc/present alcohol consumption (n = 589)70.8%/36.4%29.2%/63.6%0.006
Hypertension53.2%46.8%0.003
Dyslipidemia52.1%43.0%NS
CKD60.5%39.5%0.004
Overweight45.7%54.3%< 0.001
Obesity42.4%56.6%< 0.001
Treatment
  Only OAD66.7%33.3%< 0.001
  OAD + insulin33.8%66.2%< 0.001
  Only basald insulin49.0%51.0%NS
  Basal + boluse insulin37.8%62.2%0.006
HbA1c (%)6.3 (4.3 - 7.9)8.7 (7.0 - 15.2)< 0.001